This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
BioDelivery Sciences (NASDAQ: BDSI) is a specialty pharmaceutical company that is utilizing licensed and owned proprietary drug delivery technologies to develop and commercialize new formulations of proven therapeutics. BDSI also gets A’s in Earnings Momentum and Equity. Shares of BDSI are up more than fivefold since the start of the year, better than the 12% increase the Nasdaq has seen over the same period. For more information, get Portfolio Grader’s complete analysis of BDSI stock.
Durect (NASDAQ: DRRX) is a specialty pharmaceutical company that develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms. DRRX gets A’s in Earnings Momentum, Analyst Earnings Revisions, Equity, and Cash Flow as well. The stock’s current trailing PE Ratio is 5.1. For more information, get Portfolio Grader’s complete analysis of DRRX stock.
Argan (AMEX: AGX) provides development, consulting, engineering, procurement, construction, commissioning, operations, and maintenance services to the power generation and renewable energy markets for public utilities, independent power project owners, municipalities, public institutions, and private industry. AGX also gets A’s in Earnings Growth, Earnings Momentum, and Analyst Earnings Revisions. For more information, get Portfolio Grader’s complete analysis of AGX stock.
Gold Resource (AMEX: GORO) explores for gold and other precious metals. GORO also gets A’s in Earnings Growth and Equity. For more information, get Portfolio Grader’s complete analysis of GORO stock.
Medley Capital (NYSE: MCC) is a private owned investment management firm. MCC also gets an A in Earnings Growth. Shares of MCC are up 17.4% since January 1. For more information, get Portfolio Grader’s complete analysis of MCC stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.